Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: Positive effects on major symptoms of atopic dermatitis and on quality of life.

Autor: Sunderkötter, Cord, Weiss, Johannes M., Bextermöller, Raphael, Löffler, Helena, Schneider, Dirk
Zdroj: Journal der Deutschen Dermatologischen Gesellschaft; apr2006, Vol. 4 Issue 4, p301-306, 6p
Databáze: Complementary Index
Externí odkaz: